Treace Medical Concepts, Inc. Accrued Liabilities, Current
Treace Medical Concepts, Inc. (TMCI) had Accrued Liabilities, Current of $6.28 million as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2026-08-07
- 2026-06-30: Accrued Liabilities, Current $6.28M.
- 2026-03-31: Accrued Liabilities, Current $5.98M.
- 2025-12-31: Accrued Liabilities, Current $5.78M.
- 2025-09-30: Accrued Liabilities, Current $7.32M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2026-06-30 | $6.28M 10-Q · filed 2026-08-07 |
| 2026-03-31 | $5.98M 10-Q · filed 2026-05-08 |
| 2025-12-31 | $5.78M 10-Q · filed 2026-08-07 |
| 2025-09-30 | $7.32M 10-Q · filed 2025-11-06 |
| 2025-06-30 | $6.19M 10-Q · filed 2025-08-07 |
| 2025-03-31 | $6.01M 10-Q · filed 2025-05-08 |
| 2024-12-31 | $7.20M 10-K · filed 2026-02-27 |
| 2024-09-30 | $8.10M 10-Q · filed 2024-11-05 |
| 2024-06-30 | $13.73M 10-Q · filed 2024-08-06 |
| 2024-03-31 | $15.15M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $10.46M 10-K · filed 2025-02-27 |
| 2023-09-30 | $8.94M 10-Q · filed 2023-11-09 |
| 2023-06-30 | $7.07M 10-Q · filed 2023-08-09 |
| 2023-03-31 | $7.97M 10-Q · filed 2023-05-09 |
| 2022-12-31 | $6.22M 10-K · filed 2024-02-27 |
| 2022-09-30 | $5.19M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $4.81M 10-Q · filed 2022-08-10 |
| 2022-03-31 | $3.55M 10-Q · filed 2022-05-06 |
| 2021-12-31 | $4.52M 10-K · filed 2023-03-08 |
| 2021-09-30 | $2.82M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $1.96M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $2.82M 10-Q · filed 2021-05-25 |
| 2020-12-31 | $1.85M 10-K · filed 2022-03-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |